NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 23 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | +600.0% | 14,720 | +852.1% | 0.00% | – |
| Q1 2022 | $1,000 | -80.0% | 1,546 | -62.9% | 0.00% | – |
| Q4 2021 | $5,000 | – | 4,169 | +3034.6% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 133 | -96.8% | 0.00% | – |
| Q2 2021 | $14,000 | -46.2% | 4,192 | -29.9% | 0.00% | – |
| Q1 2021 | $26,000 | +188.9% | 5,978 | +236.0% | 0.00% | – |
| Q4 2020 | $9,000 | -60.9% | 1,779 | -56.0% | 0.00% | – |
| Q3 2020 | $23,000 | -43.9% | 4,046 | -20.9% | 0.00% | -100.0% |
| Q2 2020 | $41,000 | +720.0% | 5,117 | +1313.5% | 0.00% | – |
| Q1 2020 | $5,000 | – | 362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $191,000 | 0.02% |
| FNY Investment Advisers, LLC | 10,000 | $33,000 | 0.01% |
| SG3 Management, LLC | 50,000 | $167,000 | 0.01% |
| PITCAIRN CO | 12,351 | $41,000 | 0.00% |
| Ergoteles LLC | 30,800 | $103,000 | 0.00% |
| Advisory Services Network, LLC | 8,550 | $28,000 | 0.00% |
| HRT FINANCIAL LP | 18,759 | $62,000 | 0.00% |
| UBS Group AG | 2,881 | $10,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,062 | $4,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 320 | $1,000 | 0.00% |